Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Huazhong University of Science and Technology is the lead sponsor of 50 current clinical trials in our China register. 27 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Bupivacaine, Ropivacaine and Cholecalciferol. The most-studied condition is Postoperative Pain.

ClinicalTrials.gov trials by status

Recruiting2754%
Not yet open1530%
Active, closed48%
By invitation48%

Trials by phase

Not applicable2652%
Observational1326%
Phase 4612%
Phase 236%
Phase 324%

Clinical trials sponsored by Huazhong University of Science and Technology

50 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC NCT06168786 · ClinicalTrials.gov ↗ · Colorectal Cancer Drugs: Cadonilimab, Fruquintinib	Phase 2	Recruiting	2023-06	China
The ED95 of Ciprofol for Laryngeal Mask Airway Insertion With Fentanyl in Children: A Biased-Coin Dose-Finding Trial NCT07697404 · ClinicalTrials.gov ↗ · Pediatric, Anesthesia Induction, Ciprofol Drugs: Ciprofol, Fentanyl	Phase 4	Recruiting	2026-06	China
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes. NCT07019012 · ClinicalTrials.gov ↗ · T2DM Drugs: Cofrogliptin, Linagliptin, Metformin	Phase 4	Recruiting	2025-07	China
Bupivacaine Liposomes or Bupivacaine for CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery NCT06737341 · ClinicalTrials.gov ↗ · Bupivacaine, Ultrasound-Guided, Analgesia, Postoperative Drugs: Bupivacaine, Bupivacaine Liposomes	Phase 4	Recruiting	2025-10	China
Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes NCT06861062 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2 Drug: Cholecalciferol	Not applicable	Recruiting	2025-04	China
Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty NCT07509866 · ClinicalTrials.gov ↗ · Total Knee Anthroplasty, Nerve Block, Ropivacaine Drug: Liposomal bupivacaine	Not applicable	Recruiting	2026-04	China
Analysis of the Incidence and Risk Factors of Chronic Pain After Cesarean Section NCT06704490 · ClinicalTrials.gov ↗ · Postoperative Pain, Cesarean Section Surgery	Observational	Recruiting	2024-02	China
Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF NCT04533295 · ClinicalTrials.gov ↗ · Repeated Implantation Failure	Not applicable	Recruiting	2020-11	China
Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia NCT07410702 · ClinicalTrials.gov ↗ · Altered State of Consciousness, General Anesthetics	Observational	Recruiting	2026-02	China
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data NCT07463872 · ClinicalTrials.gov ↗ · Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas, Intraductal Papillary Mucinous Neoplasm of Pancreas	Observational	Recruiting	2025-01	China
Perioperative EEG-Monitoring and Emergence Delirium in Children NCT04091724 · ClinicalTrials.gov ↗ · Delirium	Observational	Recruiting	2019-12	China
QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty NCT07771829 · ClinicalTrials.gov ↗ · Pain Management, Arthroplasty Total Hip Replacement Drug: Ropivacaine	Not applicable	Recruiting	2026-08	China
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery NCT04733820 · ClinicalTrials.gov ↗ · Uterine Cervical Neoplasms, Cervical Cancer	Phase 3	Recruiting	2021-02	China
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection NCT03491605 · ClinicalTrials.gov ↗ · EBV Infection	Observational	Recruiting	2019-07	China
Comparison of pCLE and EB in Gastric Lesion Diagnosis NCT06389448 · ClinicalTrials.gov ↗ · Low Grade Intraepithelial Neoplasia, High Grade Intraepithelial Neoplasia, Early Gastric Cancer	Not applicable	Recruiting	2024-04	China
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) NCT06565910 · ClinicalTrials.gov ↗ · Femoral Neck Fractures, Femur Head Necrosis, Hip Fractures Drugs: Bupivacaine, Liposomal bupivacaine, Ropivacaine	Phase 4	Recruiting	2024-12	China
Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled Trial NCT07331363 · ClinicalTrials.gov ↗ · Breast Cancer, Ultrasound	Not applicable	Recruiting	2025-12	China
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis NCT07078136 · ClinicalTrials.gov ↗ · Submucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma	Observational	Recruiting	2025-07	China
Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor NCT05632107 · ClinicalTrials.gov ↗ · Neuromuscular Blockade	Observational	Recruiting	2023-03	China
Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health NCT07005193 · ClinicalTrials.gov ↗ · Cardiopulmonary Function, Environmental Exposures	Not applicable	Recruiting	2025-07	China
Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients NCT06678529 · ClinicalTrials.gov ↗ · Delirium - Postoperative, Hip Fractures (ICD-10 72.01-72.2)	Not applicable	Recruiting	2024-11	China
Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery NCT04832568 · ClinicalTrials.gov ↗ · Delirium	Observational	Recruiting	2021-06	China
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression NCT06005870 · ClinicalTrials.gov ↗ · Diffuse Large B Cell Lymphoma Drug: Zanubrutinib	Phase 2	Recruiting	2022-11	China
Minimum Effective Dose of Ropivacaine for Ultrasound-guided Interscalene Block NCT07326943 · ClinicalTrials.gov ↗ · Hand and Forearm Trauma, Hand and Forearm Diseases	Not applicable	Recruiting	2026-05	China
Effects of Vitamin D and Prebiotic Supplementation on Glucose Control During Pregnancy NCT06553729 · ClinicalTrials.gov ↗ · Glucose Intolerance During Pregnancy Drug: Cholecalciferol	Not applicable	Recruiting	2025-02	China
Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia NCT06449547 · ClinicalTrials.gov ↗ · Herpes Zoster	Observational	Recruiting	2024-06	China
Exploring of Serum Biomarkers of Delirium After Cardiovascular Surgery NCT06007755 · ClinicalTrials.gov ↗ · Delirium	Observational	Recruiting	2023-09	China
QLESP Block for Pain Control in Robotic Partial Nephrectomy NCT07704970 · Renal Cell Carcinoma (Kidney Cancer), Postoperative Pain, Nerve Block Drug: Ropivacaine	Not applicable	Not yet open	2026-07	China
Brain Stimulation for Postherpetic Neuralgia: A Randomized Sham-Controlled Trial NCT07352553 · Postherpetic Neuralgia	Not applicable	Not yet open	2026-01	China
22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions NCT07012694 · ClinicalTrials.gov ↗ · Pancreatic Neoplasms, Mediastinal Neoplasms, Abdominal Neoplasm, Excluding Pancreas Neoplasm	Not applicable	Not yet open	2025-07	China
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) NCT07555730 · ClinicalTrials.gov ↗ · Overweight or Obesity; Type 2 Diabetes, Weight Loss Maintenance Drug: Tirzepatide	Phase 4	Not yet open	2026-04	China
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions NCT06753318 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Pancreatitis, Pancreatic Neuroendocine Neoplasms (pNETs)	Not applicable	Not yet open	2025-01	China
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases NCT07448376 · ClinicalTrials.gov ↗ · CTCs, Pancreatic Cancer, Liver Metastases	Observational	Not yet open	2026-03	China
RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET NCT07769684 · ClinicalTrials.gov ↗ · Diminished Ovarian Reserve (DOR), Infertility (IVF Patients)	Not applicable	Not yet open	2026-08	China
Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement NCT06653621 · ClinicalTrials.gov ↗ · Knee Arthropathy, Knee Arthritis Drugs: Bupivacaine, Bupivacaine liposome	Phase 4	Not yet open	2024-11	China
Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss NCT07611552 · ClinicalTrials.gov ↗ · Obesity & Overweight	Not applicable	Not yet open	2026-06	China
Effect of Acupuncture on the Success Rate in Patients With Recurrent Implantation Failure NCT07486297 · ClinicalTrials.gov ↗ · Implantation Failure	Not applicable	Not yet open	2026-06	China
The Influence of Explainability and Integrability of AI-CDSS on Usage Behavior Among Primary Care Physicians NCT07401979 · ClinicalTrials.gov ↗ · Respiratory Tract Infections (RTI)	Not applicable	Not yet open	2026-02	China
CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study NCT07106411 · ClinicalTrials.gov ↗ · Submucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma	Observational	Not yet open	2025-08	China
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome NCT07240376 · ClinicalTrials.gov ↗ · Non-Allergic Rhinitis With Eosinophilia Syndrome Drug: Stapokibart	Not applicable	Not yet open	2025-11	China
Efficacy and Safety of Calculus Bovis Sativus in Adults With MAFLD NCT07085962 · ClinicalTrials.gov ↗ · Metabolic Dysfunction-associated Fatty Liver Disease Drug: Calculus bovis sativus	Not applicable	Not yet open	2025-08	China
Yeast Protein Supplementation and Muscle Preservation During GLP-1RA-Induced Weight Loss NCT07817823 · ClinicalTrials.gov ↗ · Overweight and Obesity in Adults Receiving GLP-1RA Treatment	Not applicable	Not yet open	2026-09	China
Interventions on Non-prescription Dispensing of Antibiotics in Community Pharmacies NCT06521892 · ClinicalTrials.gov ↗ · Non-Prescription Drug Misuse, Acute Respiratory Tract Infection	Not applicable	By invitation	2024-08	China
Positive Psychology-Based Intervention Program for Postpartum Depression Within Primary Healthcare System NCT06770244 · ClinicalTrials.gov ↗ · Postpartum Depression (PPD)	Not applicable	By invitation	2025-02	China
School-EduSmoke: A Cluster Randomized Controlled Trial for Promoting Smoking Cessation Among Parents of Schoolchildren NCT06853483 · ClinicalTrials.gov ↗ · Smoking Cessation	Not applicable	By invitation	2025-05	China
Comparison of the Effects of Hydromorphone and Nalbuphine Patient Controlled Analgesia in Postoperative Pain After Cesarean Section NCT06716359 · ClinicalTrials.gov ↗ · Postoperative Pain, Patiet Controlled Analgesia	Observational	By invitation	2024-12	China
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline NCT04723875 · ClinicalTrials.gov ↗ · Uterine Cervical Neoplasms, Cervical Cancer Drugs: Carboplatin, Cisplatin, Docetaxel	Phase 3	Active, closed	2021-01	China
Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer NCT03955185 · ClinicalTrials.gov ↗ · Uterine Cervical Neoplasm	Not applicable	Active, closed	2019-05	China
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers NCT06990256 · ClinicalTrials.gov ↗ · Sleep Disorder, Aging	Not applicable	Active, closed	2025-09	China
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer NCT04516616 · ClinicalTrials.gov ↗ · Uterine Cervical Neoplasm, Uterine Cervical Cancer, Cervical Cancer Drugs: Albumin-Bound Paclitaxel, Cisplatin	Phase 2	Active, closed	2020-12	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Huazhong University of Science and Technology trials

23 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Huazhong University of Science and Technology trials

86 conditions

Postoperative Pain3 Delirium3 Cervical Cancer3Nerve Block2Pancreatic Cancer2 Uterine Cervical Neoplasms2Submucosal Tumor2Gastrointestinal Stromal Tumor (GIST)2Leiomyoma2Uterine Cervical Neoplasm2Renal Cell Carcinoma (Kidney Cancer)1Postherpetic Neuralgia1Colorectal Cancer1 Pancreatic Neoplasms1Mediastinal Neoplasms1Abdominal Neoplasm, Excluding Pancreas Neoplasm1Overweight or Obesity; Type 2 Diabetes1Weight Loss Maintenance1Non-Prescription Drug Misuse1Acute Respiratory Tract Infection1Pediatric1Anesthesia Induction1Ciprofol1Laryngeal Mask Airway1

By trial register

Register	Trials	Recruiting
Clinical trials in China	50	27

A trial with sites in more than one country appears in each of those registers.

Questions about Huazhong University of Science and Technology trials

How many clinical trials does Huazhong University of Science and Technology sponsor?

Huazhong University of Science and Technology is the lead sponsor of 50 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Huazhong University of Science and Technology trials recruiting?

Yes. 27 of its 50 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Huazhong University of Science and Technology testing?

Its current trials name 23 drugs and biologicals as interventions. The most frequent are Bupivacaine (3), Ropivacaine (3), Cholecalciferol (2), Cisplatin (2) and Liposomal bupivacaine (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Sponsor	Trials
General Hospital of Ningxia Medical University	4
The Second Affiliated Hospital of Chongqing Medical University	3
Shanghai Huilun Pharmaceutical	2
Tianjin First Central Hospital	2

Huazhong University of Science and Technology clinical trials